ZJYL

6-K - Jin Medical International Ltd. (0001837821) (Filer)

3 - Jin Medical International Ltd. (0001837821) (Issuer)

3 - Jin Medical International Ltd. (0001837821) (Issuer)

3 - Jin Medical International Ltd. (0001837821) (Issuer)

3 - Jin Medical International Ltd. (0001837821) (Issuer)

3 - Jin Medical International Ltd. (0001837821) (Issuer)

6-K - Jin Medical International Ltd. (0001837821) (Filer)

CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that it has received written notification from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement. The Company regained compliance after its Class A ordinary shares maintained a closing bid price of at least $1.00 per share for more than ten (10) consecutive business days.T

6-K - Jin Medical International Ltd. (0001837821) (Filer)

CHANGZHOU, China, March 11, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that its Board of Directors has approved an 1-for-20 share combination of all its authorized and issued ordinary shares (the "Stock Combination") pursuant to the authorization granted from an extraordinary general meeting of the Company's shareholders on January 30, 2026 (the "EGM"). Effective as of the date of the EGM, the Company's authorized share capital is reclassified into a dual class of Class A ordinary shares

20-F - Jin Medical International Ltd. (0001837821) (Filer)

6-K - Jin Medical International Ltd. (0001837821) (Filer)

CHANGZHOU, China, Feb. 5, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment hosted a CEO Fireside Chat on February 2, 2026 where the CEO shared some insights into the Company's recent strategic priorities and long-term growth considerations. The following questions were prepared by the Company and addressed by the Company's CEO, Dr. Erqi Wang during the conversation. Certain statements made during the discussion were forward-looking, and the Company provided a cautionary note regarding forward-looking statements prior to the start of th

6-K - Jin Medical International Ltd. (0001837821) (Filer)

NT 20-F - Jin Medical International Ltd. (0001837821) (Filer)

6-K - Jin Medical International Ltd. (0001837821) (Filer)

CHANGZHOU, China, Jan. 26, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment in China, announced today that its Chief Executive Officer, together with the Company's management team, will host a fireside chat at 8:00 pm EST on February 1, 2026. The discussion will provide insights into the Company's recent strategic priorities and long-term growth considerations. The Company also announced the launch of its updated corporate website at http://www.jinmed.com, where the fireside chat will be webcast. About Jin Medical International Ltd. Fo

6-K - Jin Medical International Ltd. (0001837821) (Filer)

CHANGZHOU, China, Jan. 22, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment in China, announced today that its wholly-owned subsidiary, Zhongjin Medical Equipment (Anhui) Co., Ltd., has made significant progress in the final construction of its manufacturing facility in Chuzhou, Anhui Province, China. The Company is projected to launch full capacity production by the end of April 2026. The Company completed regulatory filings with the local authorities for the Chuzhou facility on December 29, 2025, and has obtained the license for Class

6-K - Jin Medical International Ltd. (0001837821) (Filer)

Changzhou, China, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment in China, announced today that members of its management team will host a fireside chat on February 1, 2026, to provide an update on the Company's strategic priorities and capital structure considerations. During the discussion, the management team will address recent market developments and outline the framework of the Company's ongoing strategic planning efforts. The fireside chat is intended to offer transparency into management's thinking and decisio

6-K - Jin Medical International Ltd. (0001837821) (Filer)

EFFECT - Jin Medical International Ltd. (0001837821) (Filer)

F-3/A - Jin Medical International Ltd. (0001837821) (Filer)

6-K - Jin Medical International Ltd. (0001837821) (Filer)